Fresenius Kabi Oncology Ltd. - Research Center
532545 FKONCO Group (B) BSE data
Results
Statement
More
| Mar ' 13 |
Mar ' 12 |
Mar ' 11 |
Mar ' 10 |
Mar ' 09 |
Equity share capital
| 15.82 |
15.82 |
15.82 |
15.82 |
15.82 |
Share application money
Preference share capital
Reserves & surplus
| 657.36 |
576.77 |
525.52 |
476.28 |
396.05 |
Secured loans
| 5.45 |
11.13 |
63.50 |
117.46 |
210.37 |
Unsecured loans
| 134.71 |
136.19 |
269.45 |
151.64 |
32.09 |
Total
| 813.34 |
739.90 |
874.29 |
761.19 |
654.33 |
Gross block
| 456.29 |
391.43 |
321.01 |
290.92 |
230.16 |
Less : revaluation reserve
Less : accumulated depreciation
| 104.55 |
82.07 |
62.71 |
46.78 |
34.65 |
Net block
| 351.74 |
309.36 |
258.30 |
244.14 |
195.51 |
Capital work-in-progress
| 163.07 |
133.82 |
98.56 |
8.73 |
2.82 |
Investments
| 0.03 |
0.03 |
126.28 |
129.40 |
129.39 |
Current assets, loans & advances
| 523.93 |
566.80 |
582.03 |
537.81 |
454.00 |
Less : current liabilities & provisions
| 225.43 |
270.23 |
191.01 |
158.88 |
127.84 |
Total net current assets
| 298.50 |
296.57 |
391.02 |
378.93 |
326.16 |
Miscellaneous expenses not written
Total
| 813.34 |
739.90 |
874.29 |
761.19 |
654.33 |
Book value of unquoted investments
| 0.03 |
0.03 |
126.28 |
129.40 |
129.39 |
Market value of quoted investments
Contingent liabilities
| 112.70 |
68.96 |
1,111.81 |
24.38 |
23.95 |
Number of equity sharesoutstanding (Lacs)
| 1582.28 |
1582.28 |
1582.28 |
1582.28 |
1582.28 |